Stay updated with breaking news from Goss associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has earned a consensus recommendation of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among […] ....
Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has been given an average recommendation of “Hold” by the six analysts that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among […] ....